nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.472	0.525	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.0484	0.0538	CbGpPWpGaD
Equilin—Estriol—ABCB1—peripheral nervous system neoplasm	0.0356	0.35	CrCbGaD
Equilin—HSD17B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0319	0.0355	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.0313	0.0348	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.0276	0.0308	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.0215	0.024	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ABCB1—peripheral nervous system neoplasm	0.0195	0.191	CrCbGaD
Equilin—HSD17B1—Disease—GNS—peripheral nervous system neoplasm	0.0186	0.0207	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.0179	0.0199	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCB1—peripheral nervous system neoplasm	0.017	0.167	CrCbGaD
Equilin—Estrone—ABCB1—peripheral nervous system neoplasm	0.0169	0.166	CrCbGaD
Equilin—HSD17B1—Metabolism—GNS—peripheral nervous system neoplasm	0.0156	0.0173	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NME1—peripheral nervous system neoplasm	0.0149	0.0166	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—COX2—peripheral nervous system neoplasm	0.0144	0.016	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.013	0.0145	CbGpPWpGaD
Equilin—HSD17B1—Disease—PPP3R1—peripheral nervous system neoplasm	0.013	0.0145	CbGpPWpGaD
Equilin—Estradiol—ABCB1—peripheral nervous system neoplasm	0.0128	0.126	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.0125	0.0139	CbGpPWpGaD
Equilin—HSD17B1—Disease—ENO2—peripheral nervous system neoplasm	0.0113	0.0125	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00987	0.011	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ENO2—peripheral nervous system neoplasm	0.00943	0.0105	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.0091	0.0101	CbGpPWpGaD
Equilin—HSD17B1—Disease—SLC2A1—peripheral nervous system neoplasm	0.00908	0.0101	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—BCHE—peripheral nervous system neoplasm	0.00797	0.00887	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.0076	0.00847	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TH—peripheral nervous system neoplasm	0.00749	0.00834	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00684	0.00761	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GNAS—peripheral nervous system neoplasm	0.00612	0.00681	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.006	0.00668	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00585	0.00651	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00557	0.00621	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00511	0.0057	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTPN11—peripheral nervous system neoplasm	0.00508	0.00565	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB2—peripheral nervous system neoplasm	0.00401	0.00447	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00355	0.00396	CbGpPWpGaD
Equilin—HSD17B1—Disease—NRAS—peripheral nervous system neoplasm	0.00305	0.0034	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—peripheral nervous system neoplasm	0.00284	0.00317	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00281	0.00313	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00255	0.00284	CbGpPWpGaD
Equilin—HSD17B1—Disease—HRAS—peripheral nervous system neoplasm	0.00223	0.00249	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00214	0.00238	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.00199	0.00222	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—peripheral nervous system neoplasm	0.00197	0.0022	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—peripheral nervous system neoplasm	0.00165	0.00184	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.00163	0.00182	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.00156	0.00174	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.00138	0.00154	CbGpPWpGaD
